Volume 10, Number 12—December 2004
Research
Crimean-Congo Hemorrhagic Fever, Mauritania
Pierre Nabeth*
, Dah Ould Cheikh†, Baidy Lo‡, Ousmane Faye*, Idoumou Ould Mohamed Vall†, Mbayame Niang*, Bocar Wague†, Djibril Diop‡, Mawlouth Diallo*, Boubacar Diallo§, Ousmane Madiagne Diop*, and François Simon*
, Dah Ould Cheikh†, Baidy Lo‡, Ousmane Faye*, Idoumou Ould Mohamed Vall†, Mbayame Niang*, Bocar Wague†, Djibril Diop‡, Mawlouth Diallo*, Boubacar Diallo§, Ousmane Madiagne Diop*, and François Simon*Table 1
Distribution of Crimean-Congo hemorrhagic fever cases that were confirmed by serologic test, Mauritania, February–August 2003
| Laboratory testa | No. positive (%)b |
|---|---|
| ELISA-IgM | 22 (64.7) |
| RT-PCR | 1 (2.9) |
| Isolation | 2 (5.9) |
| ELISA-IgM + RT-PCR | 6 (17.6) |
| ELISA-IgM + RT-PCR + isolation | 3 (8.8) |
| Total | 34 (100.0) |
aELISA, enzyme-linked immunosorbent assay; RT-PCR, reverse transcription–polymerase chain reaction; Ig, immunoglobulin.
bAn additional 4 persons met the criteria for having a probable case but died before sampling, so their cases could not be confirmed with serologic tests; according to the case definition, these persons were considered case-patients, which brings the total number of cases to 38.
